Sam Backenroth
2021 - Ohr Pharmaceutical
In 2021, Sam Backenroth earned a total compensation of $1.2M as Former Chief Financial Officer at Ohr Pharmaceutical, a 225% increase compared to previous year.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Option Awards | $639,023 |
| Salary | $363,462 |
| Other | $23,330 |
| Total | $1,165,814 |
Backenroth received $639K in option awards, accounting for 55% of the total pay in 2021.
Backenroth also received $140K in bonus, $363.5K in salary and $23.3K in other compensation.
Rankings
In 2021, Sam Backenroth's compensation ranked 8,229th out of 12,406 executives tracked by ExecPay. In other words, Backenroth earned more than 33.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,229 out of 12,406 | 34th |
Division Manufacturing | 3,640 out of 5,492 | 34th |
Major group Chemicals And Allied Products | 1,620 out of 2,368 | 32nd |
Industry group Drugs | 1,440 out of 2,089 | 31st |
Industry Pharmaceutical Preparations | 1,070 out of 1,536 | 30th |
Source: SEC filing on July 22, 2022.
Backenroth's colleagues
We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2021.